Daniel Robert Crooks1, Ye Yang2, Andrew Lane3, Teresa Fan3, Jeffrey Brender4, Murali C Krishna4, and W. Marston Linehan1
1Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States, 2National Cancer Institute, Bethesda, MD, United States, 3Center for Environmental Systems Biochemistry, University of Kentucky, Lexington, KY, United States, 4Radiation Biology Branch, National Cancer Institute, Bethesda, MD, United States
Synopsis
NMR-based
analyses of lipids can shed insight into the global complement of cellular
lipids, and elucidate the fuel sources and pathways contributing to lipid
biosynthesis in cells grown in the presence of 13C-labeled fuels. We
utilized 1H-13C HSQC NMR analysis of cellular lipids
derived from FH- and mtDNA deficient UOK271 cells and observed robust reductive
carboxylation of glutamine that resulted in formation and incorporation of 13C-glutamine-derived
acetyl groups into lipid chains.
Summary:
We
utilized 1H-13C HSQC NMR to analyze the fuel sources for
lipid biosynthesis in patient-derived fumarate hydratase (FH) and mtDNA
deficient UOK271 cells and found that 13C-glucose labeled lipid glycerol
moieties but not acyl chains, while acyl chains were robustly labeled by 13C-glutamine.
Introduction:
Hereditary
leiomyomatosis and renal cell carcinoma (HLRCC)-associated fumarate hydratase
(FH)-deficient renal cell carcinoma (RCC) is the most aggressive and lethal of
the 14 known types of genetically defined heritable forms of RCC 1-3. Previous work has demonstrated glucose-dependent growth as well as up-regulation of
the pentose phosphate pathway (PPP) providing cytosolic reducing equivalents
for anabolic reactions including lipid biosynthesis 2,4. Recently, we identified loss and mutation of mitochondrial
DNA as a hallmark of human FH-deficient tumors 5, demonstrating that this tumor type undergoes
a permanent departure from mitochondrial oxidative phosphorylation.
FH-deficient
tumor cells are able to multiply and metastasize with striking rapidity, a
process which involves a massive amount of lipid and membrane biosynthesis. The enormous chemical diversity of cellular lipids makes their detailed analysis very complex. NMR
analysis of lipids offers a unique modality to assess the global isotope
labeling patterns of cellular lipids in cells and tissues grown in the presence
of stable isotope tracers 6,7. In this study, we have utilized stable
isotope-resolved metabolomics and NMR spectroscopy to evaluate sources of de
novo lipid biosynthesis in FH- and mtDNA-deficient UOK271 tumor cells.
Methods:
Tracer
experiments were carried out in triplicate with either 10 mM 13C6-glucose
or 2mM 13C515N2-L-glutamine in DMEM
containing 10% dialyzed FBS and 1mM sodium pyruvate for 48 hours. At the end of
the tracing period, cells were extracted in acetonitrile:water:chloroform (2:1.5:1) 8.A 1:1 mixture of chloroform and methanol containing 1
mM butylated hydroxytoluene (BHT) was added to the lower non-polar fractions
obtained from the extracts described above, and the mixtures were then dried in
an Eppendorf SpeedVac.
The
resulting lipid residues were dissolved in 210 µL of d4-methanol, vortexed
vigorously, centrifuged at 20,000 x g for 5 minutes, and 200 µL of the
supernatant was transferred to disposable 3 mm Bruker SampleJet glass NMR
tubes. NMR spectra were recorded at 700Mhz with a triple inverse resonance cold
probe. 1H{13C}-HSQC spectra were recorded with an
acquisition time of 0.2 s and a relaxation delay of 1.8 s, with adiabatic
decoupling.
1H-13C HSQC NMR spectra
were referenced to the natural abundance 1H-13C BHT
tert-butyl resonance at 1.40 ppm. 1D HSQC experiments were used to estimate the
relative 13C content of different lipid functional group positions
in the extracts, and peak areas were quantified where indicated and normalized
to the methanol resonance.
Results:
Incubation
of UOK271 cells in the presence of 10 mM 13C6-glucose
resulted in robust labeling of the glycerol resonances in lipids at 5.24, 4.45,
4.43, 4.17, and 4.00 ppm as measured by 1H{13C}-HSQC,
indicating robust incorporation of glucose-derived carbon into the glycerol
moiety of cellular lipids (Figure 1). However, resonances corresponding to acyl
chain carbons and terminal omega methyl groups in 13C6-glucose-labeled
cells were comparable in intensity to spectra obtained from unlabeled cells
(Figure 1). In sharp contrast, UOK271 cells grown in the presence of 2mM 13C515N2-L-glutamine
did not show appreciable labeling of the glycerol moiety of cellular lipids,
but did show significant labeling of lipid acyl chain resonances (1.29ppm),
including those proximal to the lipid head group (2.33 and 1.60ppm), as well as
terminal ω-methyl groups (0.9ppm).
Analysis
of the fatty acid synthesis precursor molecule citrate by mass spectrometry
demonstrated that isotopic labeling of citrate by 13C6-glucose
was minimal in UOK271 cells, whereas growth of the cells in the presence of 13C515N2-L-glutamine
resulted in robust labeling of citrate with five additional mass units (m+5;
Figure 2).
Notably,
restoration of fumarate hydratase enzyme activity in UOK271 cells by stable
transfection of wild type human FH enzyme did not result in a significant
change in 13C515N2-L-glutamine
labeling of acyl chains, where empty vector-transfected UOK271 cells showed a acyl
chain peak area of 431±91 while FH-transfected UOK271 cells showed a peak area
of 408±87 (methanol-normalized; P=0.65, 2-tailed t-test).
Discussion:
Our
data demonstrate that FH- and mtDNA-deficient UOK271 tumor cells utilized
glutamine-derived carbon to de novo synthesize new cellular lipid chains, while
glucose-derived carbon was used to synthesize the glycerol backbone needed for lipids.
A profound lack of lipid acyl chain labeling from 13C6-glucose
suggests that glucose did not appreciably enter the Krebs cycle, and
concordantly citrate labeling was absent in UOK271 cells grown in the presence
of 13C6-glucose. In contrast, growth of UOK271 cells in
the presence of 13C515N2-L-glutamine
resulted in robust 13C labeling of lipid acyl chains, demonstrating
that this nutrient is important for lipid metabolism in these cells. The
prominent m+5 isotopologue labeling pattern of citrate grown in the presence of
13C515N2-L-glutamine strongly
suggests that citrate was derived by reductive carboxylation of
glutamine-derived α-ketoglutarate, a process that has been observed in other
models of FH-deficient RCC 9. Notably, reductive carboxylation of
glutamine-derived α-ketoglutarate leading to lipid biosynthesis persisted
following restoration of FH enzyme activity in the cells, suggesting that their
mtDNA deficiency strongly underlies the metabolic reprogramming observed in
these tumor cells.Acknowledgements
Funding was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute.References
1 Grubb,
R. L. et al. Hereditary
leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive
form of inherited renal cancer. J Urol
177, 2074-2080 (2007).
2 Linehan,
W. M. et al. The Metabolic Basis of
Kidney Cancer. Cancer Discov,
doi:10.1158/2159-8290.CD-18-1354 (2019).
3 Tomlinson,
I. P. et al. Germline mutations in FH
predispose to dominantly inherited uterine fibroids, skin leiomyomata and
papillary renal cell cancer. Nat Genet
30, 406-410 (2002).
4 Yang,
Y. et al. Metabolic reprogramming for
producing energy and reducing power in fumarate hydratase null cells from
hereditary leiomyomatosis renal cell carcinoma. PLoS One 8, e72179,
doi:10.1371/journal.pone.0072179 (2013).
5 Crooks,
D. R. et al. Mitochondrial DNA
alterations underlie an irreversible shift to aerobic glycolysis in fumarate
hydratase-deficient renal cancer. Sci
Signal 14,
doi:10.1126/scisignal.abc4436 (2021).
6 Crooks,
D. R. et al. Acute loss of
iron-sulfur clusters results in metabolic reprogramming and generation of lipid
droplets in mammalian cells. J Biol Chem
293, 8297-8311,
doi:10.1074/jbc.RA118.001885 (2018).
7 Lin,
P. et al. NMR Methods for Determining
Lipid Turnover via Stable Isotope Resolved Metabolomics. Metabolites 11,
doi:10.3390/metabo11040202 (2021).